New videos will be uploaded as they are received.
And thank you to all those to contributed with their videos and messages.
HAPPY LABORATORY PROFESSIONALS WEEK 2021!
Click on the image and reach the page
]]>New videos will be uploaded as they are received.
And thank you to all those to contributed with their videos and messages.
HAPPY LABORATORY PROFESSIONALS WEEK 2021!
Click on the image and reach the page
]]>
Artificial intelligence (AI) is an important emerging technology, and in the future, it is likely that this technology will become embedded in many aspects of medicine. In particular, it is expected to play a key role in laboratory medicine.
Click here to find the survey on the role of AI in genomic tests for diagnosis of COVID-19 (literature surveyed 2019 – March 2021).
]]>
Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního souhrnu o COVID 19 z 16 . dubna 2020
Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.
Click here to access to the different chapters of the IFCC Guide
Table of Contents:
_____________________________________________________________________
https://www.workcast.com/?cpak=8172916142437123&pak=9776851145646643
The webinar focused on recent laboratory techniques including metagenomic Next‐Generation Sequencing (mNGS) and digital PCR in the diagnosis of infectious diseases.
]]>
IFCC eNews: April 2021 |
 |
| Full PDF version |
IN THIS ISSUE:
Register for the next IFCC webinar!
IFCC call for nominations
Mentorship interview
The Top 10 “Count-Ups” to Healthcare Excellence at Biomédica de Referencia (Mexico)
Vaccination: the way out!
Sheila – unlocking the treatment for PKU
Malawi Association of Medical Laboratory Scientists (MAMLS): Accreditation of the first four laboratories in Malawi
News from the Spanish Society of Laboratory Medicine (SEQCML)
News from the Japan Society of Clinical Chemistry (JSCC)
EFLM Courses
Tackling the pandemic crisis in Overseas France
Calendar of IFCC Congresses/Conferences and Regional Federations' Congresses
Calendar of events with IFCC auspices
|
Número Febrero 2021 |
 |
 |
|
Click here to access the PDF version |
Click here to access the Flip version |
| EDITORIAL |
| NOVEDADES Y NOTICIAS |
|
|
| ARTÍCULOS CIENTÍFICOS |
|
| CARTAS AL EDITOR |
| REPORTAJE |
]]>
Click aquí para descargar el Resumen traducido de la Guía de Información de la IFCC sobre COVID-19
Kliknutím zde stáhnete českou verzi IFCC informačního souhrnu o COVID 19 z 16 . dubna 2020
Coronavirus disease 2019, abbreviated to COVID-19, is an emerging global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the number of individuals infected with COVID-19 continues to rise globally and healthcare systems become increasingly stressed, it is clear that the clinical laboratory will play an essential role in this crisis, contributing to patient screening, diagnosis, monitoring/treatment, as well as epidemiologic recovery/surveillance. This guide aims to organize relevant available information on laboratory screening, testing protocols, diagnosis, and other general information on COVID-19 for laboratory professionals, including links to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.
Click here to access to the different chapters of the IFCC Guide
Table of Contents:
_____________________________________________________________________
|
=================
Emerging Technologies Division
=================
Applications for these positions should be submitted by IFCC members (National Societies or Corporate members). If you are interested, please refer to your National Representative or Corporate Representative for information on procedures for nominations. Find your representative HERE
For further information on the open Calls for Nominations, please visit the IFCC Call for Nominations page.
=================
]]>
Dear Colleagues,
We are pleased to inform you that the 24th WorldLab Congress in Seoul will be held jointly with the 16th APFCB (Asia-Pacific Federation of Clinical Biochemistry) Congress in June 2022.
The IFCC and APFCB have agreed that a joint conference would be more attractive and beneficial for both conference delegates and corporate sponsors and will ensure wider participation from laboratory professionals and industry partners across Asia-Pacific and around the world.
The host Society, the Korean Society for Clinical Chemistry (KSCC) has also very graciously agreed to host the joint WorldLab-APFCB Congress in Seoul which has also been approved by the IFCC and APFCB Executive Boards.
The Joint WorldLab-APFCB Congress will be held on 26th -30th June 2022 in Seoul at the Coex Convention and Exhibition Center.
We welcome all IFCC national societies and corporate members to actively participate in this major and exciting event next year.
Yours sincerely
Prof. Khosrow Adeli
IFCC President
]]>